LUCY SCIENTIFIC DISCOVERY INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7597 USD | -12.68% |
|
-32.17% | -70.33% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Lucy Scientific Discovery Inc. is an early stage psychotropics contract manufacturing company. The Company is engaged in researching, developing, and manufacturing psychotropic drugs. The Company is a manufacturer of controlled compounds dedicated to advancing the frontiers of mind science and facilitating the development of psychotropic and psychedelic treatment therapies. It is focused on developing therapies for patients in need, and through its lead candidate SANA-013, dedicated to advancing the understanding and applications of psychedelic medicine, improving mental health outcomes, and enhancing well-being for individuals worldwide. The Company is engaged in the production of a variety of natural, synthetic, and biosynthetic products to meet the needs of the psychotropics-based medicines market. Its products are in the form of raw materials, crude extracts, targeted formulations, single molecule fractions, and white- and private-label products.
Sector
Pharmaceuticals
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -70.33% | 1.34M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- LSDI Stock
- News Lucy Scientific Discovery Inc.
- Top Premarket Gainers
